An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

A smartphone app delivering simple cognitive-behavioral skills helped significantly ease mild (subthreshold) depression, with ...

New research spotlights the habenula, a tiny but powerful brain region, as a key player in addiction, motivation, and emotional regulation.

For many people with major depression, current treatments either don’t work or take too long to show results. About one in ...

The University of Colorado Anschutz is part of a national study looking at the potential benefits and risks of psilocybin ...

A new smartphone app developed at Emory University is allowing researchers to analyze patients' voice diaries to improve their health.

A nasal spray based on a ketamine-related compound has been approved for use in Australia to treat patients with severe ...

A controversial substance once tied to underground rave culture is now being hailed as a breakthrough for depression.

Factors associated with multi-b/tsDMARD failure among patients with PsA included female sex, obesity, depression, axial disease, and increased disease activity.

The Cleveland Clinic recommends several non-medicinal methods to increase the body's production of serotonin, including ...

Treating depression is not a one-size-fits-all solution, but there has been creative steps taken to help patients manage the ...

Beta-blockers have become a commonly used and popular treatment for anxiety and panic, but research on their safety and efficacy remains uncertain.